← Leaderboards
Julia K L Walker
Duke University
$6,460,748
Attributed
$12,118,716
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,118,716 · 6
By mechanism
R01$9,859,446 · 4
P01$1,760,575 · 1
R56$498,695 · 1
Top collaborators
- Raymond B. Penn14 shared
- Richard Agustin Bond10 shared
- Hong W Chu5 shared
- Burton F Dickey4 shared
- Brian J Knoll2 shared
Most similar at Duke University
Same institution · by research overlap
- Xiao-Fan Wang$23,927,835
- Micheler Ricardo Richardson$12,273,967
- Robert J Lefkowitz$17,365,480
- Lucas Wachsmuth$145,870
- Tanya Lynn Daigle$1,615,633
Others in their field
Top investigators on “Asthma”
- James E. Gern · University Of Wisconsin-Madison$159,588,264
- William W. Busse · University Of Wisconsin Madison$104,093,792
- Scott T Weiss · University Of California, San Diego$98,211,117
- David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
- Fernando D Martinez · University Of Arizona$66,357,737
- Wanda Phipatanakul · Boston Children'S Hospital$50,505,446
Research focus
AsthmaInflammatoryCellsIn VivoMediatingAgonistSignal TransductionPhenotypeAllergensArrestinsGtp-Binding ProteinsRegulationLungSignal PathwayAirway HyperresponsivenessEpithelial CellsChronicPreventAllergicBeta-2 Adrenergic ReceptorsGenesPharmaceutical PreparationsIn VitroG-Protein-Coupled Receptors
Grant awards (26)
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$629,899
R01 · FY2025 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$629,899
R01 · FY2024 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$629,899
R01 · FY2023 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$615,316
R01 · FY2022 · AI · contact PI
Novel Biased Beta2-AR Ligands as Asthma Therapeutics$661,553
R01 · FY2021 · AI · contact PI
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma$610,966
R01 · FY2018 · AI · contact PI
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma$614,923
R01 · FY2017 · AI · contact PI
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma$621,840
R01 · FY2016 · AI · contact PI
Animal Model and Sample Analysis Core$345,400
P01 · FY2016 · HL · contact PI
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma$655,249
R01 · FY2015 · AI · contact PI
Animal Model and Sample Analysis Core$347,951
P01 · FY2015 · HL · contact PI
Optimizing Beta-Adrenoceptor Signaling Bias in Asthma$710,814
R01 · FY2014 · AI · contact PI
Animal Model and Sample Analysis Core$346,185
P01 · FY2014 · HL · contact PI
Arrestin Selectivity for GPCRs in Airway Smooth Muscle$376,813
R01 · FY2013 · HL
Animal Model and Sample Analysis Core$353,044
P01 · FY2013 · HL · contact PI
Mechanisms of Beta-blocker Induced Improvements in Asthma$58,695
R56 · FY2013 · AI
Mechanisms of Beta-blocker Induced Improvements in Asthma$440,000
R56 · FY2012 · AI
T cell function in asthma depends on a novel signaling pathway$386,100
R01 · FY2012 · HL · contact PI
Arrestin Selectivity for GPCRs in Airway Smooth Muscle$378,675
R01 · FY2012 · HL
Animal Model and Sample Analysis Core$367,995
P01 · FY2012 · HL · contact PI
T cell function in asthma depends on a novel signaling pathway$390,000
R01 · FY2011 · HL · contact PI
Arrestin Selectivity for GPCRs in Airway Smooth Muscle$382,500
R01 · FY2011 · HL
Arrestin Selectivity for GPCRs in Airway Smooth Muscle$395,000
R01 · FY2010 · HL
T cell function in asthma depends on a novel signaling pathway$390,000
R01 · FY2010 · HL · contact PI
T cell function in asthma depends on a novel signaling pathway$390,000
R01 · FY2009 · HL · contact PI
T cell function in asthma depends on a novel signaling pathway$390,000
R01 · FY2008 · HL · contact PI